Uroplasty to Issue Fourth Fiscal Quarter and Full Year Results on June 4, 2009
19 Maggio 2009 - 12:30PM
PR Newswire (US)
MINNEAPOLIS, May 19 /PRNewswire-FirstCall/ -- Uroplasty, Inc.
(AMEX:UPI) announced today that it will release financial results
for the fourth fiscal quarter and full year ended March 31, 2009,
at the market close on Thursday, June 4, 2009. The Company will
host a conference call to discuss these results on Thursday, June
4, 2009 at 3:30 p.m. Central Time. David Kaysen, President and
Chief Executive Officer, and Medi Jiwani, Vice President, Chief
Financial Officer and Treasurer, will host the call. Individuals
wishing to participate in the conference call should dial
877-941-8609 (domestic) or 480-629-9818 (international). An audio
replay will be available for 30 days following the call at
800-406-7325 (domestic) or 303-590-3030 (international), with the
passcode 4081844 #. About Uroplasty, Inc. Uroplasty, Inc.,
headquartered in Minnetonka, Minnesota, with wholly-owned
subsidiaries in The Netherlands and the United Kingdom, is a
medical device company that develops, manufactures and markets
innovative proprietary products for the treatment of voiding
dysfunctions. Our primary focus is on sales growth in the U.S.
market. We offer the Urgent PC(R) system, which we believe is the
only FDA-approved minimally invasive nerve stimulation device
designed for office-based treatment of urinary urgency, urinary
frequency and urge incontinence - symptoms often associated with
overactive bladder. We also offer Macroplastique(R) Implants, an
injectable bulking agent for the treatment of adult female stress
urinary incontinence primarily due to intrinsic sphincter
deficiency. Please visit Uroplasty, Inc. at
http://www.uroplasty.com/. For Further Information: Uroplasty, Inc.
EVC Group David Kaysen, President and CEO, or Doug
Sherk/(Investors) Medi Jiwani, Vice President, CFO, and
415.896.6820 Treasurer, Chris Gale/Steve DiMattia 952.426.6140
(Media) 646.201.5431 DATASOURCE: Uroplasty, Inc. CONTACT: David
Kaysen, President and CEO, or Medi Jiwani, Vice President, CFO, and
Treasurer, both at +1-952-426-6140, both of Uroplasty, Inc.; or
Investors, Doug Sherk, +1-415-896-6820, or Media, Chris Gale, or
Steve DiMattia, both at +1-646-201-5431, all of EVC Group, for
Uroplasty, Inc. Web Site: http://www.uroplasty.com/
Copyright
Grafico Azioni Uroplasty (AMEX:UPI)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Uroplasty (AMEX:UPI)
Storico
Da Mag 2023 a Mag 2024